Episodes (Page 2)
✨
Post-cancer incontinence significantly impacts quality of life.
Andrew Peterson, MD
✨
Karen Bigman discusses midlife sexual health and intimacy challenges.
Karen Bigman
✨
Independent urology faces threats from stagnant pay and rising costs.
Celeste Kirschner
✨
Counsel patients on TRT, GLP-1s, and peptide stacking using evidence tiers.
✨
Dr. Matin discusses perioperative chemotherapy for bladder recurrence after nephroureterectomy.
✨
NeoBLAST trial investigates active surveillance for MIBC patients.
✨
Celeste Kirschner outlines LUGPA's 2027 health policy priorities.
Celeste Kirschner
✨
Prof. Murphy discusses PROTEUS trial pathologic response findings.
✨
APPs guide patients through genetic testing process.
✨
UF urology chiefs share residency reflections.
✨
GemFLP shows promise for urinary tract adenocarcinomas.
Emanuele Crupi
✨
Differentiating bladder dysfunction from obstruction post-BPH.
✨
Emergency physician transitions to sexual medicine.
✨
APPs' expanding role in cystoscopy procedures.
Davis Viprakasit
✨
ASCO 2026 highlights key GU oncology themes.
Maria Natalia Gandur Quiroga
✨
Cribriform histology is an important adverse feature in prostate cancer.
✨
POISE-3 trial evaluated tranexamic acid in urologic surgery.
Kari Tikkinen
Expert APProach: Advancing APP Leadership & Expertise in Urology, With Susanne Quallich, PhD, ANP-BC
✨
APP leadership and specialization in urology discussed.
Susanne Quallich
✨
Advances in advanced prostate cancer care highlighted.
✨
N-of-1 trial shows varied tamsulosin responses.